Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Open channel block of Kv1.5 currents by citalopram.

Lee HM, Hahn SJ, Choi BH.

Acta Pharmacol Sin. 2010 Apr;31(4):429-35. doi: 10.1038/aps.2010.14. Epub 2010 Mar 15.

2.

Inhibitory action of fluvoxamine on Kv1.5 currents.

Lee HM, Hahn SJ, Choi BH.

Biol Pharm Bull. 2010;33(6):977-82.

3.

Open channel block of Kv3.1 currents by fluoxetine.

Sung MJ, Ahn HS, Hahn SJ, Choi BH.

J Pharmacol Sci. 2008 Jan;106(1):38-45. Epub 2008 Jan 11.

4.

Blockade of Kv1.5 channels by the antidepressant drug sertraline.

Lee HM, Hahn SJ, Choi BH.

Korean J Physiol Pharmacol. 2016 Mar;20(2):193-200. doi: 10.4196/kjpp.2016.20.2.193. Epub 2016 Feb 23.

5.

Blockade of Kv1.5 by paroxetine, an antidepressant drug.

Lee HM, Hahn SJ, Choi BH.

Korean J Physiol Pharmacol. 2016 Jan;20(1):75-82. doi: 10.4196/kjpp.2016.20.1.75. Epub 2015 Dec 31.

6.

Effects of dapoxetine on cloned Kv1.5 channels expressed in CHO cells.

Jeong I, Yoon SH, Hahn SJ.

Naunyn Schmiedebergs Arch Pharmacol. 2012 Jul;385(7):707-16. doi: 10.1007/s00210-012-0754-y. Epub 2012 Apr 27.

PMID:
22538641
7.

Direct block by bisindolylmaleimide of rat Kv1.5 expressed in Chinese hamster ovary cells.

Choi BH, Choi JS, Jeong SW, Hahn SJ, Yoon SH, Jo YH, Kim MS.

J Pharmacol Exp Ther. 2000 May;293(2):634-40.

8.

Pergolide block of the cloned Kv1.5 potassium channels.

Jeong I, Choi BH, Hahn SJ.

Naunyn Schmiedebergs Arch Pharmacol. 2013 Feb;386(2):125-33. doi: 10.1007/s00210-012-0776-5. Epub 2012 Jul 5.

PMID:
22763615
9.

Direct inhibition of the cloned Kv1.5 channel by AG-1478, a tyrosine kinase inhibitor.

Choi BH, Choi JS, Rhie DJ, Yoon SH, Min DS, Jo YH, Kim MS, Hahn SJ.

Am J Physiol Cell Physiol. 2002 Jun;282(6):C1461-8.

10.

Effects of norfluoxetine, the major metabolite of fluoxetine, on the cloned neuronal potassium channel Kv3.1.

Choi BH, Choi JS, Yoon SH, Rhie DJ, Min DS, Jo YH, Kim MS, Hahn SJ.

Neuropharmacology. 2001 Sep;41(4):443-53.

PMID:
11543764
11.

Effects of lobeline, a nicotinic receptor ligand, on the cloned Kv1.5.

Jeong I, Choi BH, Hahn SJ.

Pflugers Arch. 2010 Oct;460(5):851-62. doi: 10.1007/s00424-010-0868-3. Epub 2010 Aug 24.

PMID:
20734202
12.

Open channel block of A-type, kv4.3, and delayed rectifier K+ channels, Kv1.3 and Kv3.1, by sibutramine.

Kim SE, Ahn HS, Choi BH, Jang HJ, Kim MJ, Rhie DJ, Yoon SH, Jo YH, Kim MS, Sung KW, Hahn SJ.

J Pharmacol Exp Ther. 2007 May;321(2):753-62. Epub 2007 Feb 20.

13.

Carvedilol blocks the cloned cardiac Kv1.5 channels in a β-adrenergic receptor-independent manner.

Jeong I, Choi BH, Yoon SH, Hahn SJ.

Biochem Pharmacol. 2012 Feb 15;83(4):497-505. doi: 10.1016/j.bcp.2011.11.019. Epub 2011 Nov 28.

PMID:
22146582
14.

Staurosporine directly blocks Kv1.3 channels expressed in Chinese hamster ovary cells.

Choi JS, Hahn SJ, Rhie DJ, Jo YH, Kim MS.

Naunyn Schmiedebergs Arch Pharmacol. 1999 Apr;359(4):256-61.

PMID:
10344523
15.

Open channel block of Kv1.3 by rosiglitazone and troglitazone: Kv1.3 as the pharmacological target for rosiglitazone.

Ahn HS, Kim SE, Jang HJ, Kim MJ, Rhie DJ, Yoon SH, Jo YH, Kim MS, Sung KW, Kim SY, Hahn SJ.

Naunyn Schmiedebergs Arch Pharmacol. 2007 Jan;374(4):305-9. Epub 2006 Nov 21.

PMID:
17119927
16.

Effect of psoralen on the cloned Kv3.1 currents.

Sung MJ, Hahn SJ, Choi BH.

Arch Pharm Res. 2009 Mar;32(3):407-12. doi: 10.1007/s12272-009-1314-y. Epub 2009 Apr 23.

PMID:
19387585
17.

Mechanism of fluoxetine block of cloned voltage-activated potassium channel Kv1.3.

Choi JS, Hahn SJ, Rhie DJ, Yoon SH, Jo YH, Kim MS.

J Pharmacol Exp Ther. 1999 Oct;291(1):1-6.

18.

Cinnamyl-3,4-dihydroxy-alpha-cyanocinnamate and nordihydroguaiaretic acid inhibit human Kv1.5 currents independently of lipoxygenase.

Gong YZ, Ding WG, Wu J, Tsuji K, Horie M, Matsuura H.

Eur J Pharmacol. 2008 Dec 14;600(1-3):18-25. doi: 10.1016/j.ejphar.2008.10.010. Epub 2008 Oct 10.

PMID:
18930721
19.

Inhibitory actions of the phosphatidylinositol 3-kinase inhibitor LY294002 on the human Kv1.5 channel.

Wu J, Ding WG, Matsuura H, Tsuji K, Zang WJ, Horie M.

Br J Pharmacol. 2009 Jan;156(2):377-87. doi: 10.1111/j.1476-5381.2008.00017.x. Epub 2009 Jan 16.

20.

Characterization of mibefradil block of the human heart delayed rectifier hKv1.5.

Perchenet L, Clément-Chomienne O.

J Pharmacol Exp Ther. 2000 Nov;295(2):771-8.

Supplemental Content

Support Center